iRadimed (IRMD) Competitors $56.82 +0.53 (+0.93%) As of 11:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IRMD vs. WRBY, LIVN, EYE, NVCR, LMAT, ENOV, CNMD, CDRE, AORT, and ESTAShould you be buying iRadimed stock or one of its competitors? The main competitors of iRadimed include Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), CONMED (CNMD), Cadre (CDRE), Artivion (AORT), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. iRadimed vs. Its Competitors Warby Parker LivaNova National Vision NovoCure LeMaitre Vascular Enovis CONMED Cadre Artivion Establishment Labs Warby Parker (NYSE:WRBY) and iRadimed (NASDAQ:IRMD) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends. Which has stronger valuation and earnings, WRBY or IRMD? iRadimed has lower revenue, but higher earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$795.09M3.19-$20.39M-$0.12-202.18iRadimed$73.24M9.87$19.23M$1.5536.66 Which has more volatility & risk, WRBY or IRMD? Warby Parker has a beta of 2.09, indicating that its share price is 109% more volatile than the S&P 500. Comparatively, iRadimed has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Do analysts recommend WRBY or IRMD? Warby Parker currently has a consensus price target of $22.88, indicating a potential downside of 5.71%. iRadimed has a consensus price target of $72.00, indicating a potential upside of 26.70%. Given iRadimed's stronger consensus rating and higher probable upside, analysts plainly believe iRadimed is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 9 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.53iRadimed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer WRBY or IRMD? In the previous week, Warby Parker had 8 more articles in the media than iRadimed. MarketBeat recorded 8 mentions for Warby Parker and 0 mentions for iRadimed. Warby Parker's average media sentiment score of 0.65 beat iRadimed's score of 0.00 indicating that Warby Parker is being referred to more favorably in the media. Company Overall Sentiment Warby Parker Positive iRadimed Neutral Is WRBY or IRMD more profitable? iRadimed has a net margin of 26.33% compared to Warby Parker's net margin of -1.79%. iRadimed's return on equity of 23.28% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.79% -2.48% -1.29% iRadimed 26.33%23.28%20.59% Do institutionals and insiders believe in WRBY or IRMD? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 92.3% of iRadimed shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by insiders. Comparatively, 36.8% of iRadimed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryiRadimed beats Warby Parker on 10 of the 16 factors compared between the two stocks. Get iRadimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRMD vs. The Competition Export to ExcelMetriciRadimedMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$722.81M$6.91B$5.63B$9.41BDividend Yield1.21%1.31%4.01%4.02%P/E Ratio36.6626.0428.4320.05Price / Sales9.8772.33415.6587.96Price / Cash35.5120.0435.9658.29Price / Book8.304.748.525.82Net Income$19.23M$176.14M$3.24B$258.18M7 Day Performance-1.87%3.00%4.58%3.68%1 Month Performance-4.48%5.55%12.60%14.51%1 Year Performance19.71%6.31%35.87%19.00% iRadimed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRMDiRadimed4.5386 of 5 stars$56.83+0.9%$72.00+26.7%+22.2%$722.81M$73.24M36.66110Upcoming EarningsWRBYWarby Parker2.6494 of 5 stars$23.02+3.7%$22.88-0.6%+52.9%$2.41B$795.09M-191.803,780Insider TradeLIVNLivaNova3.3648 of 5 stars$43.97-0.8%$59.29+34.8%-19.7%$2.40B$1.25B-10.752,900Positive NewsEYENational Vision2.7825 of 5 stars$25.01+2.2%$22.10-11.6%+89.2%$1.98B$1.82B-75.7913,411Analyst ForecastNVCRNovoCure3.7007 of 5 stars$17.42-1.0%$32.43+86.2%-13.7%$1.94B$605.22M-11.541,488Upcoming EarningsLMATLeMaitre Vascular2.7114 of 5 stars$84.09+0.5%$97.83+16.3%-9.0%$1.90B$226.26M42.47490Analyst ForecastENOVEnovis2.914 of 5 stars$31.91-6.2%$55.60+74.3%-40.5%$1.82B$2.15B-2.297,367CNMDCONMED4.8064 of 5 stars$50.04-2.4%$62.20+24.3%-32.0%$1.55B$1.31B13.173,900Positive NewsUpcoming EarningsCDRECadre3.3684 of 5 stars$33.47+2.1%$37.50+12.0%-13.6%$1.36B$567.56M35.232,284Dividend AnnouncementAORTArtivion2.9302 of 5 stars$31.68+0.7%$32.40+2.3%+10.9%$1.35B$390.08M-63.361,600News CoveragePositive NewsESTAEstablishment Labs2.063 of 5 stars$45.53+1.4%$51.80+13.8%-8.2%$1.32B$166.02M-14.691,018 Related Companies and Tools Related Companies WRBY Competitors LIVN Competitors EYE Competitors NVCR Competitors LMAT Competitors ENOV Competitors CNMD Competitors CDRE Competitors AORT Competitors ESTA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRMD) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRadimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share iRadimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRMD Stock Alerts